Cargando…
The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment
BACKGROUND AND PURPOSE: Two Chinese herbal medicines Huang Qi (HQ, Astragalus mongholicus) and Dan Shen (DS, Salvia miltiorrhiza) are often combined to treat coronary heart disease (CHD). The purpose of this study was to identify the underlying synergistic effects and mechanisms of HQ and DS against...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486279/ https://www.ncbi.nlm.nih.gov/pubmed/34611395 http://dx.doi.org/10.2147/DDDT.S326024 |
_version_ | 1784577716743307264 |
---|---|
author | Zhang, Yun Wang, Jie Liu, Yong-Mei Chen, Yin-Ying Yang, Xiao-Chen Duan, Lian |
author_facet | Zhang, Yun Wang, Jie Liu, Yong-Mei Chen, Yin-Ying Yang, Xiao-Chen Duan, Lian |
author_sort | Zhang, Yun |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Two Chinese herbal medicines Huang Qi (HQ, Astragalus mongholicus) and Dan Shen (DS, Salvia miltiorrhiza) are often combined to treat coronary heart disease (CHD). The purpose of this study was to identify the underlying synergistic effects and mechanisms of HQ and DS against CHD. METHODS: The active components and targets of HQ and DS, CHD-related genes, and the biological progression were analysed by network pharmacology. The myocardial infarction (MI) rat model was established by ligating the left anterior descending coronary artery. Cardiac function was detected by ultrasonic electrocardiography. The MI size, fibrosis, cardiac hypertrophy, lipid metabolism, blood viscosity, and coagulation indexes were analysed by histological staining or chemical methods, respectively. RESULTS: A total of 170 shared and specific seed genes of HQ and DS against CHD were identified. The shared and specific biological processes of HQ and DS against CHD were obtained. The LVEF and LVFS values significantly increased, the myocardium infarct size and fibrosis significantly decreased, the values of lipid metabolism indexes and blood viscosity indexes significantly reduced in the HQ + DS treatment group vs HQ or DS single treatment (P < 0.05); the LVEDd, LVEDs, and the CSA values significantly reduced in HQ single and HQ + DS treatment groups vs MI group (P < 0.05); the coagulation index (APTT, PT, TT, and FIB) values decreased significantly in the DS single and HQ + DS treatment groups vs MI group (P < 0.05). CONCLUSION: In MI rats, HQ and DS exhibited synergistic effects on improving cardiac function, reducing MI size, fibrosis, regulating hyperlipidaemia, and maintaining circulatory system homeostasis; HQ had the specific advantage of alleviating cardiac remodelling; DS had the specific advantage of regulating hypercoagulability. This study revealed that HQ and DS not only exerted synergistic effects but also exhibited complementary effects on CHD. |
format | Online Article Text |
id | pubmed-8486279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-84862792021-10-04 The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment Zhang, Yun Wang, Jie Liu, Yong-Mei Chen, Yin-Ying Yang, Xiao-Chen Duan, Lian Drug Des Devel Ther Original Research BACKGROUND AND PURPOSE: Two Chinese herbal medicines Huang Qi (HQ, Astragalus mongholicus) and Dan Shen (DS, Salvia miltiorrhiza) are often combined to treat coronary heart disease (CHD). The purpose of this study was to identify the underlying synergistic effects and mechanisms of HQ and DS against CHD. METHODS: The active components and targets of HQ and DS, CHD-related genes, and the biological progression were analysed by network pharmacology. The myocardial infarction (MI) rat model was established by ligating the left anterior descending coronary artery. Cardiac function was detected by ultrasonic electrocardiography. The MI size, fibrosis, cardiac hypertrophy, lipid metabolism, blood viscosity, and coagulation indexes were analysed by histological staining or chemical methods, respectively. RESULTS: A total of 170 shared and specific seed genes of HQ and DS against CHD were identified. The shared and specific biological processes of HQ and DS against CHD were obtained. The LVEF and LVFS values significantly increased, the myocardium infarct size and fibrosis significantly decreased, the values of lipid metabolism indexes and blood viscosity indexes significantly reduced in the HQ + DS treatment group vs HQ or DS single treatment (P < 0.05); the LVEDd, LVEDs, and the CSA values significantly reduced in HQ single and HQ + DS treatment groups vs MI group (P < 0.05); the coagulation index (APTT, PT, TT, and FIB) values decreased significantly in the DS single and HQ + DS treatment groups vs MI group (P < 0.05). CONCLUSION: In MI rats, HQ and DS exhibited synergistic effects on improving cardiac function, reducing MI size, fibrosis, regulating hyperlipidaemia, and maintaining circulatory system homeostasis; HQ had the specific advantage of alleviating cardiac remodelling; DS had the specific advantage of regulating hypercoagulability. This study revealed that HQ and DS not only exerted synergistic effects but also exhibited complementary effects on CHD. Dove 2021-09-27 /pmc/articles/PMC8486279/ /pubmed/34611395 http://dx.doi.org/10.2147/DDDT.S326024 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Yun Wang, Jie Liu, Yong-Mei Chen, Yin-Ying Yang, Xiao-Chen Duan, Lian The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment |
title | The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment |
title_full | The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment |
title_fullStr | The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment |
title_full_unstemmed | The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment |
title_short | The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment |
title_sort | synergistic effects of astragalus mongholicus and salvia miltiorrhiza on coronary heart disease identified by network pharmacology and experiment |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486279/ https://www.ncbi.nlm.nih.gov/pubmed/34611395 http://dx.doi.org/10.2147/DDDT.S326024 |
work_keys_str_mv | AT zhangyun thesynergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT wangjie thesynergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT liuyongmei thesynergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT chenyinying thesynergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT yangxiaochen thesynergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT duanlian thesynergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT zhangyun synergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT wangjie synergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT liuyongmei synergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT chenyinying synergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT yangxiaochen synergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment AT duanlian synergisticeffectsofastragalusmongholicusandsalviamiltiorrhizaoncoronaryheartdiseaseidentifiedbynetworkpharmacologyandexperiment |